Avantor, Inc.
ISIN US05352A1007
|WKN A2PJN6
Market cap (in EUR)
7,167 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the following geographical segments: the Americas, Europe, and AMEA. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Healthcare Healthcare Services Healthcare Support Services United States
Financials
Key metrics
| Market capitalisation, EUR | 7,167 m |
| EPS, EUR | -0.11 |
| P/B ratio | 1.5 |
| P/E ratio | 15.0 |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 6,271 m |
| Net income, EUR | 658 m |
| Profit margin | 10.49% |
What ETF is Avantor, Inc. in?
There are 12 ETFs which contain Avantor, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Avantor, Inc. is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.